Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series

Breast cancer is one of the most common female cancers and the leading cause of cancer death in women. The method of positron emission tomography, combined with computed tomography, makes it possible to assess not only anatomical and structural, but also metabolic changes in tumor tissue. The increa...

Full description

Bibliographic Details
Main Authors: A. V. Parnas, A. I. Pronin, V. S. Ilyakov, N. A. Meshcheryakova, Z. Kh. Kamolova, D. I. Nevzorov
Format: Article
Language:Russian
Published: ABV-press 2021-09-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/847
_version_ 1797876013234913280
author A. V. Parnas
A. I. Pronin
V. S. Ilyakov
N. A. Meshcheryakova
Z. Kh. Kamolova
D. I. Nevzorov
author_facet A. V. Parnas
A. I. Pronin
V. S. Ilyakov
N. A. Meshcheryakova
Z. Kh. Kamolova
D. I. Nevzorov
author_sort A. V. Parnas
collection DOAJ
description Breast cancer is one of the most common female cancers and the leading cause of cancer death in women. The method of positron emission tomography, combined with computed tomography, makes it possible to assess not only anatomical and structural, but also metabolic changes in tumor tissue. The increased accumulation of 18F-fluoroestradiol in the pathological focus correlates with the estrogen receptor-positive status of the tumor, which is confirmed by tissue immunohistochemistry studies. The receptor status of a tumor formation fundamentally affects the choice of therapeutic tactics. The presented clinical examples demonstrate the capabilities of positron emission tomography, combined with computed tomography, with 18F-fluoroestradiol in the diagnosis of the estrogen receptor-positive tumor lesions.
first_indexed 2024-04-10T01:55:27Z
format Article
id doaj.art-87f300d475984f2a838ba8925179efd5
institution Directory Open Access Journal
issn 1994-4098
1999-8627
language Russian
last_indexed 2024-04-10T01:55:27Z
publishDate 2021-09-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj.art-87f300d475984f2a838ba8925179efd52023-03-13T08:44:38ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272021-09-0117210.17650/1994-4098-2021-17-2-75-80689Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case seriesA. V. Parnas0A. I. Pronin1V. S. Ilyakov2N. A. Meshcheryakova3Z. Kh. Kamolova4D. I. Nevzorov5ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава РоссииФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава РоссииBreast cancer is one of the most common female cancers and the leading cause of cancer death in women. The method of positron emission tomography, combined with computed tomography, makes it possible to assess not only anatomical and structural, but also metabolic changes in tumor tissue. The increased accumulation of 18F-fluoroestradiol in the pathological focus correlates with the estrogen receptor-positive status of the tumor, which is confirmed by tissue immunohistochemistry studies. The receptor status of a tumor formation fundamentally affects the choice of therapeutic tactics. The presented clinical examples demonstrate the capabilities of positron emission tomography, combined with computed tomography, with 18F-fluoroestradiol in the diagnosis of the estrogen receptor-positive tumor lesions.https://ojrs.abvpress.ru/ojrs/article/view/847пэт / кт18f-фэсрецепторы эстрогенарак молочной железы
spellingShingle A. V. Parnas
A. I. Pronin
V. S. Ilyakov
N. A. Meshcheryakova
Z. Kh. Kamolova
D. I. Nevzorov
Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series
Опухоли женской репродуктивной системы
пэт / кт
18f-фэс
рецепторы эстрогена
рак молочной железы
title Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series
title_full Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series
title_fullStr Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series
title_full_unstemmed Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series
title_short Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series
title_sort utility of sup 18 sup f fluoroestradiol pet ct in the differential diagnosis of estrogen receptor positive breast cancer case series
topic пэт / кт
18f-фэс
рецепторы эстрогена
рак молочной железы
url https://ojrs.abvpress.ru/ojrs/article/view/847
work_keys_str_mv AT avparnas utilityofsup18supffluoroestradiolpetctinthedifferentialdiagnosisofestrogenreceptorpositivebreastcancercaseseries
AT aipronin utilityofsup18supffluoroestradiolpetctinthedifferentialdiagnosisofestrogenreceptorpositivebreastcancercaseseries
AT vsilyakov utilityofsup18supffluoroestradiolpetctinthedifferentialdiagnosisofestrogenreceptorpositivebreastcancercaseseries
AT nameshcheryakova utilityofsup18supffluoroestradiolpetctinthedifferentialdiagnosisofestrogenreceptorpositivebreastcancercaseseries
AT zkhkamolova utilityofsup18supffluoroestradiolpetctinthedifferentialdiagnosisofestrogenreceptorpositivebreastcancercaseseries
AT dinevzorov utilityofsup18supffluoroestradiolpetctinthedifferentialdiagnosisofestrogenreceptorpositivebreastcancercaseseries